Xian Lin Li
Président chez Shanghai Fosun New Drug Research Co., Ltd.
Profil
Xian Lin Li is currently the Chairman at Shanghai Fosun New Drug Research Co., Ltd.
and Director at Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd.
Previously, he held the position of Chairman at Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.
and Director at Tianjin Pharmaceuticals Group Co., Ltd.
From 2004 to 2015, he served as Senior Vice President at Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Postes actifs de Xian Lin Li
Sociétés | Poste | Début |
---|---|---|
Shanghai Fosun New Drug Research Co., Ltd. | Président | - |
Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd.
Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd. Drugstore ChainsRetail Trade Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd. engages in the manufacture and sale of medicine for human or veterinary use. The company was founded on September 27, 2006 and is headquartered in Xuzhou, China. | Directeur/Membre du Conseil | - |
Anciens postes connus de Xian Lin Li
Sociétés | Poste | Fin |
---|---|---|
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. Financial ConglomeratesFinance Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. engages in the investment in pharmaceutical industries. Its business activities include industrial investment; biotechnology development; and research and development of medical devices, chemical reagents and medicines. The company was founded on November 27, 2001 and is headquartered in Shanghai, China. | Président | 22/08/2016 |
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Corporate Officer/Principal | 25/02/2015 |
Tianjin Pharmaceuticals Group Co., Ltd.
Tianjin Pharmaceuticals Group Co., Ltd. Pharmaceuticals: OtherHealth Technology Tianjin Pharmaceuticals Group Co., Ltd. engages in the scientific research, production, and export of corticosteroids. Its key products include corticosteroid raw materials and formulations, amino acid raw materials and formulations, chemical drugs, cardiovascular drugs, external preparations, contraceptives, Chinese prepared medicines, and health products, etc. The company was founded on July 9, 1988 and is headquartered in Tianjin, China. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Health Technology |
Entreprise privées | 4 |
---|---|
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. Financial ConglomeratesFinance Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. engages in the investment in pharmaceutical industries. Its business activities include industrial investment; biotechnology development; and research and development of medical devices, chemical reagents and medicines. The company was founded on November 27, 2001 and is headquartered in Shanghai, China. | Finance |
Tianjin Pharmaceuticals Group Co., Ltd.
Tianjin Pharmaceuticals Group Co., Ltd. Pharmaceuticals: OtherHealth Technology Tianjin Pharmaceuticals Group Co., Ltd. engages in the scientific research, production, and export of corticosteroids. Its key products include corticosteroid raw materials and formulations, amino acid raw materials and formulations, chemical drugs, cardiovascular drugs, external preparations, contraceptives, Chinese prepared medicines, and health products, etc. The company was founded on July 9, 1988 and is headquartered in Tianjin, China. | Health Technology |
Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd.
Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd. Drugstore ChainsRetail Trade Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd. engages in the manufacture and sale of medicine for human or veterinary use. The company was founded on September 27, 2006 and is headquartered in Xuzhou, China. | Retail Trade |
Shanghai Fosun New Drug Research Co., Ltd. |